PLATINUM INVESTMENT MANAGEMENT LTD 13D/13G Filings for Esperion Therapeutics, Inc. (ESPR)

PLATINUM INVESTMENT MANAGEMENT LTD 13D and 13G filings for Esperion Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-10
5:25 pm
Purchase
2021-12-3113GEsperion Therapeutics, Inc.
ESPR
PLATINUM INVESTMENT MANAGEMENT LTD2,713,176
3.940%
2,713,176increase
(New Position)
Filing